Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clover Fonterra Ingredients (CFI) was a joint venture between Australia's Clover Corporation and New Zealand's Fonterra, focused on the global supply of nutritional lipid ingredients. The company specialized in microencapsulation technology, which allowed for the stable incorporation of docosahexaenoic acid (DHA) and other omega-3 fatty acids into infant formula and functional foods. CFI served as the primary marketing and sales arm for Clover's Nu-Mega brand of tuna oils and encapsulated powders. The joint venture was dissolved in late 2013, after which Clover Corporation internalised its sales and marketing operations to engage more directly with its global customer base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clover Fonterra Ingredients.